Michael Noel Cocchi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Out-of-Hospital Cardiac Arrest | 19 | 2021 | 338 | 2.980 |
Why?
|
Heart Arrest | 29 | 2022 | 1469 | 2.900 |
Why?
|
Lactic Acid | 13 | 2020 | 1132 | 1.710 |
Why?
|
Shock, Septic | 13 | 2023 | 773 | 1.690 |
Why?
|
Cardiopulmonary Resuscitation | 25 | 2020 | 974 | 1.660 |
Why?
|
Ubiquinone | 5 | 2021 | 188 | 1.250 |
Why?
|
Hypothermia, Induced | 11 | 2021 | 747 | 1.070 |
Why?
|
Thiamine | 9 | 2023 | 152 | 1.060 |
Why?
|
Cytochromes c | 4 | 2019 | 180 | 1.060 |
Why?
|
Rewarming | 4 | 2021 | 61 | 0.990 |
Why?
|
Shock | 4 | 2019 | 318 | 0.970 |
Why?
|
Vasoconstrictor Agents | 7 | 2022 | 643 | 0.950 |
Why?
|
Intensive Care Units | 13 | 2023 | 3679 | 0.910 |
Why?
|
Propanolamines | 1 | 2022 | 167 | 0.800 |
Why?
|
Hospital Mortality | 19 | 2021 | 5310 | 0.690 |
Why?
|
Patient Transfer | 4 | 2021 | 760 | 0.620 |
Why?
|
Sepsis | 11 | 2018 | 2589 | 0.590 |
Why?
|
Balloon Occlusion | 1 | 2017 | 126 | 0.560 |
Why?
|
Angiotensin II | 1 | 2019 | 881 | 0.550 |
Why?
|
Esophageal and Gastric Varices | 1 | 2017 | 207 | 0.510 |
Why?
|
Teaching Rounds | 1 | 2018 | 253 | 0.480 |
Why?
|
APACHE | 2 | 2012 | 277 | 0.440 |
Why?
|
Body Temperature | 6 | 2021 | 776 | 0.430 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 950 | 0.420 |
Why?
|
Micronutrients | 1 | 2015 | 375 | 0.420 |
Why?
|
Critical Care | 8 | 2022 | 2640 | 0.410 |
Why?
|
Pyruvate Dehydrogenase Complex | 3 | 2016 | 56 | 0.400 |
Why?
|
Bacterial Infections | 1 | 2020 | 1389 | 0.400 |
Why?
|
Respiratory Insufficiency | 6 | 2017 | 1199 | 0.380 |
Why?
|
Catheterization, Central Venous | 1 | 2015 | 514 | 0.380 |
Why?
|
Resuscitation | 2 | 2022 | 657 | 0.370 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2043 | 0.360 |
Why?
|
Brain Edema | 2 | 2014 | 617 | 0.350 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1130 | 0.350 |
Why?
|
Hypothermia | 1 | 2011 | 189 | 0.340 |
Why?
|
Severity of Illness Index | 11 | 2022 | 15530 | 0.340 |
Why?
|
Fever | 2 | 2013 | 1612 | 0.330 |
Why?
|
Transportation of Patients | 2 | 2021 | 185 | 0.300 |
Why?
|
Middle Aged | 63 | 2022 | 213127 | 0.290 |
Why?
|
Ascorbic Acid | 2 | 2020 | 647 | 0.270 |
Why?
|
Neuromuscular Blockade | 2 | 2020 | 146 | 0.270 |
Why?
|
Humans | 98 | 2023 | 742088 | 0.270 |
Why?
|
Pandemics | 3 | 2021 | 8328 | 0.260 |
Why?
|
Aged | 53 | 2022 | 162944 | 0.250 |
Why?
|
Male | 71 | 2022 | 349538 | 0.250 |
Why?
|
Fluid Therapy | 2 | 2015 | 592 | 0.250 |
Why?
|
Prospective Studies | 24 | 2021 | 53187 | 0.240 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 854 | 0.240 |
Why?
|
Adrenergic beta-Agonists | 2 | 2016 | 346 | 0.230 |
Why?
|
Urinary Tract Infections | 2 | 2023 | 786 | 0.230 |
Why?
|
Respiration, Artificial | 5 | 2021 | 2566 | 0.230 |
Why?
|
Intuition | 1 | 2003 | 20 | 0.230 |
Why?
|
Thiamine Deficiency | 2 | 2016 | 43 | 0.220 |
Why?
|
Retrospective Studies | 28 | 2023 | 77098 | 0.210 |
Why?
|
Female | 67 | 2022 | 379592 | 0.210 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2010 | 1016 | 0.210 |
Why?
|
Coma | 2 | 2017 | 475 | 0.200 |
Why?
|
Epinephrine | 2 | 2016 | 793 | 0.200 |
Why?
|
Acidosis, Lactic | 3 | 2013 | 142 | 0.200 |
Why?
|
Emergency Medical Services | 4 | 2018 | 1914 | 0.200 |
Why?
|
Interleukins | 2 | 2016 | 791 | 0.190 |
Why?
|
Catheter-Related Infections | 1 | 2023 | 252 | 0.190 |
Why?
|
Diabetic Ketoacidosis | 2 | 2016 | 247 | 0.190 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1847 | 0.190 |
Why?
|
Survival Analysis | 7 | 2020 | 10248 | 0.190 |
Why?
|
Hypertension | 1 | 2019 | 8455 | 0.170 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2020 | 147 | 0.170 |
Why?
|
Tachycardia | 1 | 2022 | 620 | 0.170 |
Why?
|
Norepinephrine | 1 | 2022 | 909 | 0.170 |
Why?
|
Emergency Service, Hospital | 13 | 2020 | 7645 | 0.170 |
Why?
|
Leukocytes, Mononuclear | 2 | 2016 | 1835 | 0.160 |
Why?
|
Catecholamines | 1 | 2019 | 387 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11690 | 0.160 |
Why?
|
Cross Infection | 3 | 2023 | 1413 | 0.160 |
Why?
|
Health Care Rationing | 1 | 2022 | 435 | 0.160 |
Why?
|
Cytokines | 2 | 2016 | 7317 | 0.160 |
Why?
|
Standard of Care | 1 | 2022 | 562 | 0.160 |
Why?
|
Vital Signs | 2 | 2017 | 141 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1967 | 0.160 |
Why?
|
Perioperative Care | 2 | 2015 | 997 | 0.160 |
Why?
|
Tidal Volume | 2 | 2017 | 489 | 0.150 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 389 | 0.150 |
Why?
|
Stroke | 2 | 2019 | 9963 | 0.150 |
Why?
|
Treatment Failure | 3 | 2020 | 2615 | 0.150 |
Why?
|
Resuscitation Orders | 1 | 2019 | 267 | 0.150 |
Why?
|
Referral and Consultation | 2 | 2022 | 3527 | 0.150 |
Why?
|
Logistic Models | 8 | 2016 | 13403 | 0.140 |
Why?
|
Prognosis | 7 | 2019 | 29010 | 0.140 |
Why?
|
Aged, 80 and over | 24 | 2021 | 57683 | 0.140 |
Why?
|
Creatinine | 2 | 2023 | 1916 | 0.140 |
Why?
|
American Heart Association | 3 | 2015 | 1055 | 0.140 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2017 | 186 | 0.140 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 632 | 0.140 |
Why?
|
Documentation | 1 | 2022 | 865 | 0.130 |
Why?
|
Double-Blind Method | 7 | 2021 | 12017 | 0.130 |
Why?
|
Disease Management | 4 | 2019 | 2450 | 0.130 |
Why?
|
Nervous System Diseases | 3 | 2017 | 1617 | 0.130 |
Why?
|
Survivors | 4 | 2017 | 2286 | 0.130 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 707 | 0.130 |
Why?
|
Pulse | 1 | 2014 | 229 | 0.120 |
Why?
|
Wounds and Injuries | 1 | 2007 | 2400 | 0.120 |
Why?
|
Unnecessary Procedures | 1 | 2018 | 431 | 0.120 |
Why?
|
Patient Care Team | 2 | 2018 | 2527 | 0.120 |
Why?
|
Adult | 30 | 2021 | 213712 | 0.120 |
Why?
|
Practice Guidelines as Topic | 5 | 2019 | 7276 | 0.120 |
Why?
|
Advanced Cardiac Life Support | 1 | 2014 | 70 | 0.120 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 345 | 0.120 |
Why?
|
Treatment Outcome | 15 | 2021 | 62966 | 0.120 |
Why?
|
Predictive Value of Tests | 10 | 2017 | 15056 | 0.120 |
Why?
|
Mouth Floor | 1 | 2013 | 34 | 0.120 |
Why?
|
Coronary Artery Bypass | 2 | 2016 | 2281 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2003 | 1237 | 0.110 |
Why?
|
ROC Curve | 4 | 2017 | 3528 | 0.110 |
Why?
|
Medicine | 1 | 2022 | 941 | 0.110 |
Why?
|
Judgment | 1 | 2015 | 281 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.110 |
Why?
|
Patient Admission | 1 | 2020 | 1380 | 0.110 |
Why?
|
Registries | 7 | 2017 | 8077 | 0.110 |
Why?
|
Boston | 3 | 2022 | 9305 | 0.110 |
Why?
|
Hot Temperature | 1 | 2018 | 1355 | 0.110 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 609 | 0.110 |
Why?
|
Withholding Treatment | 1 | 2016 | 598 | 0.110 |
Why?
|
Leadership | 1 | 2021 | 1357 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2022 | 2049 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2267 | 0.100 |
Why?
|
Physicians | 2 | 2020 | 4554 | 0.100 |
Why?
|
Survival Rate | 5 | 2017 | 12773 | 0.100 |
Why?
|
Family | 2 | 2022 | 3144 | 0.100 |
Why?
|
Hydrocortisone | 2 | 2018 | 1825 | 0.100 |
Why?
|
Pilot Projects | 5 | 2016 | 8297 | 0.100 |
Why?
|
Hemodynamics | 1 | 2022 | 4197 | 0.100 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 814 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 316 | 0.100 |
Why?
|
Arctic Regions | 1 | 2011 | 25 | 0.100 |
Why?
|
Critical Illness | 3 | 2023 | 2665 | 0.100 |
Why?
|
Myoclonus | 1 | 2011 | 104 | 0.100 |
Why?
|
Artifacts | 1 | 2020 | 1903 | 0.100 |
Why?
|
Anti-Bacterial Agents | 3 | 2020 | 7153 | 0.100 |
Why?
|
Respiratory Rate | 1 | 2012 | 162 | 0.100 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2749 | 0.090 |
Why?
|
Regional Health Planning | 1 | 2011 | 97 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3766 | 0.090 |
Why?
|
Cohort Studies | 9 | 2018 | 40450 | 0.090 |
Why?
|
Inpatients | 2 | 2019 | 2495 | 0.090 |
Why?
|
Critical Pathways | 1 | 2013 | 475 | 0.090 |
Why?
|
Quality Improvement | 2 | 2022 | 3738 | 0.090 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 941 | 0.090 |
Why?
|
United States | 15 | 2020 | 69693 | 0.080 |
Why?
|
Flank Pain | 1 | 2009 | 43 | 0.080 |
Why?
|
Electrocardiography | 2 | 2020 | 6440 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1255 | 0.080 |
Why?
|
Microcirculation | 1 | 2013 | 1285 | 0.080 |
Why?
|
Calibration | 1 | 2011 | 815 | 0.080 |
Why?
|
Body Temperature Regulation | 2 | 2021 | 252 | 0.080 |
Why?
|
Time Factors | 8 | 2019 | 40054 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1541 | 0.080 |
Why?
|
Hospitalization | 4 | 2023 | 10232 | 0.080 |
Why?
|
Positive-Pressure Respiration | 1 | 2012 | 632 | 0.080 |
Why?
|
Electric Countershock | 3 | 2016 | 535 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3611 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3502 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4414 | 0.080 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1179 | 0.080 |
Why?
|
Models, Organizational | 1 | 2011 | 574 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1472 | 0.070 |
Why?
|
Cannabinoids | 1 | 2009 | 166 | 0.070 |
Why?
|
Bacteremia | 2 | 2012 | 962 | 0.070 |
Why?
|
Area Under Curve | 1 | 2011 | 1653 | 0.070 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2010 | 326 | 0.070 |
Why?
|
Nausea | 1 | 2009 | 665 | 0.070 |
Why?
|
Leukocyte Count | 1 | 2010 | 1583 | 0.070 |
Why?
|
Vomiting | 1 | 2009 | 632 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2895 | 0.070 |
Why?
|
Cause of Death | 1 | 2016 | 3571 | 0.070 |
Why?
|
Kidney | 2 | 2023 | 7167 | 0.070 |
Why?
|
Recovery of Function | 2 | 2017 | 2924 | 0.070 |
Why?
|
Patient Discharge | 3 | 2015 | 3300 | 0.070 |
Why?
|
Quality of Health Care | 2 | 2019 | 4369 | 0.070 |
Why?
|
Shock, Hemorrhagic | 1 | 2007 | 220 | 0.070 |
Why?
|
Marijuana Abuse | 1 | 2009 | 402 | 0.070 |
Why?
|
Coronary Angiography | 1 | 2017 | 4567 | 0.070 |
Why?
|
Emergency Medicine | 1 | 2014 | 1205 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8333 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4214 | 0.060 |
Why?
|
Hospitals, Urban | 3 | 2012 | 499 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8662 | 0.060 |
Why?
|
Mitochondria | 1 | 2017 | 3520 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2271 | 0.060 |
Why?
|
Vitamins | 1 | 2011 | 1608 | 0.050 |
Why?
|
Urinary Catheterization | 1 | 2023 | 201 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Length of Stay | 2 | 2015 | 6294 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39004 | 0.050 |
Why?
|
Incidence | 3 | 2016 | 20928 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2732 | 0.050 |
Why?
|
Advisory Committees | 2 | 2015 | 773 | 0.050 |
Why?
|
Catheters, Indwelling | 1 | 2023 | 425 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2016 | 15244 | 0.050 |
Why?
|
Prone Position | 1 | 2021 | 194 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20086 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13256 | 0.050 |
Why?
|
Propensity Score | 2 | 2017 | 1771 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 3915 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 82 | 0.040 |
Why?
|
Internationality | 2 | 2015 | 1002 | 0.040 |
Why?
|
Cardiology | 1 | 2011 | 1658 | 0.040 |
Why?
|
Hypotension | 2 | 2017 | 880 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1737 | 0.040 |
Why?
|
Hyperglycemia | 2 | 2020 | 1368 | 0.040 |
Why?
|
Prevalence | 4 | 2015 | 15194 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6483 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4681 | 0.040 |
Why?
|
Risk Factors | 5 | 2017 | 72145 | 0.040 |
Why?
|
Health Priorities | 1 | 2022 | 379 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2019 | 299 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2018 | 2885 | 0.040 |
Why?
|
Risk Assessment | 2 | 2017 | 23320 | 0.040 |
Why?
|
Intention | 1 | 2020 | 338 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3239 | 0.040 |
Why?
|
Ribonuclease P | 1 | 2017 | 17 | 0.040 |
Why?
|
Probability | 1 | 2003 | 2502 | 0.040 |
Why?
|
Medical Futility | 1 | 2018 | 126 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2011 | 3258 | 0.040 |
Why?
|
Specialization | 1 | 2022 | 777 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 10578 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2022 | 685 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2011 | 4231 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2009 | 2370 | 0.030 |
Why?
|
Protective Agents | 1 | 2017 | 156 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12242 | 0.030 |
Why?
|
Regression Analysis | 2 | 2017 | 6452 | 0.030 |
Why?
|
Partial Pressure | 1 | 2015 | 253 | 0.030 |
Why?
|
Japan | 1 | 2019 | 1360 | 0.030 |
Why?
|
Young Adult | 6 | 2021 | 56350 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7141 | 0.030 |
Why?
|
Comorbidity | 3 | 2017 | 10372 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 381 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 24913 | 0.030 |
Why?
|
Internship and Residency | 1 | 2014 | 5774 | 0.030 |
Why?
|
Cardiac Care Facilities | 1 | 2013 | 35 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12344 | 0.030 |
Why?
|
PubMed | 1 | 2013 | 122 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 2018 | 736 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3339 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5304 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1184 | 0.030 |
Why?
|
Lactates | 1 | 2013 | 432 | 0.030 |
Why?
|
Nursing Homes | 1 | 2019 | 1034 | 0.030 |
Why?
|
Oximetry | 1 | 2015 | 467 | 0.030 |
Why?
|
Perception | 1 | 2018 | 1188 | 0.030 |
Why?
|
Random Allocation | 1 | 2016 | 2425 | 0.020 |
Why?
|
Self Efficacy | 1 | 2014 | 610 | 0.020 |
Why?
|
Qualitative Research | 1 | 2019 | 2680 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 463 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2372 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2900 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 571 | 0.020 |
Why?
|
Ultrasonography | 1 | 2003 | 5978 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1869 | 0.020 |
Why?
|
Urban Health Services | 1 | 2010 | 179 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1887 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14720 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 21719 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3728 | 0.020 |
Why?
|
Observation | 1 | 2010 | 312 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1780 | 0.020 |
Why?
|
Educational Measurement | 1 | 2014 | 1206 | 0.020 |
Why?
|
Consensus | 1 | 2016 | 2935 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1889 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3151 | 0.020 |
Why?
|
Emotions | 1 | 2018 | 2657 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2266 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2970 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3391 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5948 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3839 | 0.020 |
Why?
|
Health Status | 1 | 2017 | 4030 | 0.010 |
Why?
|
Hippocampus | 1 | 2016 | 3661 | 0.010 |
Why?
|
Liver Diseases | 1 | 2012 | 1252 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4091 | 0.010 |
Why?
|
Data Collection | 1 | 2012 | 3339 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9679 | 0.010 |
Why?
|
Hospitals | 1 | 2016 | 3937 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9581 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2354 | 0.010 |
Why?
|
Adolescent | 2 | 2023 | 85649 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5705 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9941 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9846 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19862 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18355 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21821 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18006 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12958 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81045 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168561 | 0.000 |
Why?
|